DAIDS Core Risk List (side effects/risks of study drug) for Dolutegravir (DTG) version 2.0, September 2018
The DAIDS Core Risk Lists provides the DAIDS Medical Officer with a list of recommended risks (side effects) that will be used in the DAIDS Sample Informed Consent (SIC) Form. The list draws on all relevant sources of risk information. The risk list is usually reviewed by the protocol team with guidance from the DAIDS Medical Officer before it is included in the DAIDS Sample Informed Consent (SIC) Form.
Document Date
Saturday, September 1, 2018